1. Home
  2. AVY vs RDY Comparison

AVY vs RDY Comparison

Compare AVY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVY
  • RDY
  • Stock Information
  • Founded
  • AVY 1935
  • RDY 1984
  • Country
  • AVY United States
  • RDY India
  • Employees
  • AVY N/A
  • RDY N/A
  • Industry
  • AVY Containers/Packaging
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVY Consumer Discretionary
  • RDY Health Care
  • Exchange
  • AVY Nasdaq
  • RDY Nasdaq
  • Market Cap
  • AVY 13.1B
  • RDY 11.8B
  • IPO Year
  • AVY N/A
  • RDY N/A
  • Fundamental
  • Price
  • AVY $165.66
  • RDY $14.65
  • Analyst Decision
  • AVY Buy
  • RDY Strong Buy
  • Analyst Count
  • AVY 10
  • RDY 2
  • Target Price
  • AVY $197.00
  • RDY $16.95
  • AVG Volume (30 Days)
  • AVY 546.7K
  • RDY 770.2K
  • Earning Date
  • AVY 10-22-2025
  • RDY 11-04-2025
  • Dividend Yield
  • AVY 2.27%
  • RDY 0.49%
  • EPS Growth
  • AVY 14.63
  • RDY 2.20
  • EPS
  • AVY 8.92
  • RDY 0.79
  • Revenue
  • AVY $8,737,900,000.00
  • RDY $3,897,394,052.00
  • Revenue This Year
  • AVY $2.20
  • RDY $7.33
  • Revenue Next Year
  • AVY $3.95
  • RDY $1.96
  • P/E Ratio
  • AVY $18.57
  • RDY $18.74
  • Revenue Growth
  • AVY 1.66
  • RDY 15.86
  • 52 Week Low
  • AVY $157.00
  • RDY $12.26
  • 52 Week High
  • AVY $224.38
  • RDY $16.19
  • Technical
  • Relative Strength Index (RSI)
  • AVY 39.51
  • RDY 59.74
  • Support Level
  • AVY $164.30
  • RDY $14.54
  • Resistance Level
  • AVY $168.86
  • RDY $14.35
  • Average True Range (ATR)
  • AVY 2.83
  • RDY 0.15
  • MACD
  • AVY -0.46
  • RDY 0.06
  • Stochastic Oscillator
  • AVY 9.64
  • RDY 85.29

About AVY Avery Dennison Corporation

Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: